Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Business Development Manager

At ImmuONE, our vision is to transform in vitro inhalation safety assessment by providing the best-in-class in vitro models and tailored in vitro services that most accurately predict in vivo outcomes. We have unique capabilities in the development and commercialisation of immunocompetent 2D and 3D in vitro models and assessments and work with the pharmaceutical, consumer product and chemical sectors globally to provide vital data on safety of new products and pharmacology and efficacy of new therapeutics.

NRG Therapeutics Announces Further Expansion with the Appointment of Paul Thompson as Chief Development Officer

Stevenage, UK, 1 December 2025 - NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce expansion of its team with the appointment of Paul Thompson PhD as Chief Development Officer (CDO).

o2h Discovery wins the “Best Industry Support Partner of the Year” Award at OBN Awards 2025

We are pleased to share that o2h Discovery has been recognised as the ‘Best Industry Support Partner of the Year’ at the OBN Awards 2025. This achievement reflects the dedication of our exceptional teams and the strong, collaborative partnerships we have built with various innovative biotech and pharma organisations worldwide.
 

Programme Manager

About us

The Francis Crick Institute is Europe’s largest biomedical research institute under one roof. Our world-class scientists and staff collaborate on vital research to help prevent, diagnose and treat illnesses such as cancer, heart disease, infectious diseases and neurodegenerative conditions.  

Program Lead – (Phase I) Immune-oncology

Never losing sight of our purpose

At Mestag we truly believe in our values and live by them every day.  We’re ambitious about our science and its potential to deliver meaningful therapeutics to the patients that need them most. We believe in a culture of diversity, equality and investing in people to ensure our talented and passionate team members can fulfil their full potential.

We are now transitioning our lead programme into clinic - There has never been a better time to join #TeamMestag

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC Partnership designed to provide innovator biopharma companies with end-to-end Chemistry, Manufacturing and Controls (CMC) services. The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing.

Building the Next Generation of Leaders in Life Sciences – Lessons from a QA Perspective

As the founder of BHMP Network, Abiola Mariah will explore how inclusive and adaptive leadership practices, informed by QA principles, can strengthen regulatory compliance, foster innovation, and drive equitable outcomes.

The agenda will cover the evolving landscape of life sciences, key leadership challenges, core and essential skills such as emotional intelligence, collaboration, continuous learning, and accountability, all supported by real-world case studies to provide practical strategies for leadership development.

Cost: £10

Essential GCP Record Retention

In this session, Arkivum team members Rob Buckton and Tom Lynam will explore everything you need to know about retaining essential GCP records and data. This includes:
- Why retention matters, expanding on key retention regulations (EU CTR, MHRA updates and more).
- What good looks like taking into account ICH E6(R3) and ALCOA+.
- How to move towards good and why digital safeguarding and preservation are both crucial.
- How to implement a risk based approach to retention.
- Why data sprawl is a challenge and how consolidation supports compliance.

Subscribe to